Agilent Technologies Acquires Biocare Medical for $950M, Expands Cancer Diagnostics and Clinical Research Capabilities

martes, 24 de marzo de 2026, 10:47 am ET1 min de lectura
A--

Agilent Technologies to acquire Biocare Medical for $950M, expanding its pathology division and cancer diagnostics offerings. The deal is expected to be immediately accretive to Agilent's revenue mix and margins. Agilent also launched Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization, to support its growth in the sector.

Agilent Technologies Acquires Biocare Medical for $950M, Expands Cancer Diagnostics and Clinical Research Capabilities

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios